Global Orphan Drugs Market
Emerging Trends in the Orphan Drugs Industry, 2023-2028: Worldwide Market Analysis Featuring Profiles of Leading Players AstraZeneca, Eisai, Bristol Myers Squibb, and Pfizer Among Others
January 17, 2024 10:03 ET | Research and Markets
Dublin, Jan. 17, 2024 (GLOBE NEWSWIRE) -- The "Global Markets for Orphan Drugs" report has been added to ResearchAndMarkets.com's offering. The global orphan drugs market was valued at an...
Global Preclinical CRO Market
Global Preclinical CRO Market Assessment 2023-2027 Featuring Profiles of Eurofins Scientific, PRA Health Sciences, Wuxi AppTec, and Medpace Among Others
January 16, 2024 11:43 ET | Research and Markets
Dublin, Jan. 16, 2024 (GLOBE NEWSWIRE) -- The "Preclinical CRO Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global preclinical CRO market is expected to...
22157.jpg
Global CDC7 Kinase Inhibitors Clinical Trials & Market Opportunity Insight Report 2024: Combining CDC7 Kinase Inhibitors with Existing Cancer Therapies for Enhanced Efficacy
January 11, 2024 05:28 ET | Research and Markets
Dublin, Jan. 11, 2024 (GLOBE NEWSWIRE) -- The "Global CDC7 Kinase Inhibitors Clinical Trials & Market Opportunity Insight 2024" report has been added to ResearchAndMarkets.com's offering. ...
Global Rat Model Market
Rat Model Global Market Report 2023 - Partnerships and High Growth in Biomedical Research Propel the Industry Forward
January 09, 2024 14:18 ET | Research and Markets
Dublin, Jan. 09, 2024 (GLOBE NEWSWIRE) -- The "Rat Model Global Market Report 2023" has been added to ResearchAndMarkets.com's offering.The rat model market is expected to reach $2.13 billion in...
Global Pharmacovigilance Market
Global Pharmacovigilance Market Report 2023: Opportunities and Strategies to 2032 - Contract Outsourcing Dominates Pharmacovigilance Services Market
January 09, 2024 09:53 ET | Research and Markets
Dublin, Jan. 09, 2024 (GLOBE NEWSWIRE) -- The "Pharmacovigilance Global Market Opportunities and Strategies to 2032" report has been added to ResearchAndMarkets.com's offering.The global...
22157.jpg
Global Menin Inhibitor Drugs Clinical Trials & Insight Report 2023 Featuring Biomea Fusion, BioNova, Daiichi Sankyo, Easton, Eilean Therapeutics, HitGen, Janssen, and Sumitomo
December 15, 2023 04:48 ET | Research and Markets
Dublin, Dec. 15, 2023 (GLOBE NEWSWIRE) -- The "Global Menin Inhibitor Drugs Clinical Trials & Future Opportunity Insight 2023" report has been added to ResearchAndMarkets.com's offering. ...
22157.jpg
Global MCL1 Inhibitor Drug Clinical Trials & Commercialization Research Study 2023: Focus on 12 Drugs in Clinical Trials and Synribo, the 1 Commercially Approved MCL1 Inhibitor Drug
December 15, 2023 04:43 ET | Research and Markets
Dublin, Dec. 15, 2023 (GLOBE NEWSWIRE) -- The "Global MCL1 Inhibitor Drug Clinical Trials & Commercialization Opportunity Insights 2023" report has been added to ResearchAndMarkets.com's...
Peak Decreases in Body Weights
Rani Therapeutics Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin Triagonist
December 14, 2023 08:00 ET | Rani Therapeutics, LLC
- Transenteric delivery of incretin triagonist of GLP-1, GIP, glucagon receptors elicits rapid weight loss in animal study – - Preclinical data support the potential for the RaniPill platform...
Global Oncology-Based In-Vivo CRO Market
Oncology Based In-Vivo CRO Industry Experiences Surge with Innovative Solutions: Global Market Report 2023 Explores Trends and Growth Factors
December 11, 2023 04:28 ET | Research and Markets
Dublin, Dec. 11, 2023 (GLOBE NEWSWIRE) -- The "Oncology Based In-Vivo CRO Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global market for...
22157.jpg
Peptide Therapeutics Market Set to Surpass USD 80 Billion by 2029: In-Depth Analysis of Global Trends and Clinical Trials
December 06, 2023 03:48 ET | Research and Markets
Dublin, Dec. 06, 2023 (GLOBE NEWSWIRE) -- The "Global Peptide Therapeutics Market, Drug Dosage, Price & Clinical Trials Insight 2029" report has been added to ResearchAndMarkets.com's offering....